Basel, 23 October 2025 Group sales grew by 7%1 at constant exchange rates (CER; 2% in CHF) in the first nine months, driven by high demand for our innovative medicines and diagnostics.Pharmaceuticals ...
Hubbell's fair value per share has inched upward from $456.73 to $461.36, reflecting newly optimistic analyst perspectives. This adjustment comes as recent updates suggest improving company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback